Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on October 14, 2002

Hypertension. 2002
Published online before print October 14, 2002, doi: 10.1161/01.HYP.0000039505.79741.15
A more recent version of this article appeared on December 1, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/6/909    most recent
01.HYP.0000039505.79741.15v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varani, K.
Right arrow Articles by Portaluppi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varani, K.
Right arrow Articles by Portaluppi, F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Blood Pressure Medicines
*High Blood Pressure
Hazardous Substances DB
*DOXAZOSIN MESYLATE
*PROPRANOLOL HYDROCHLORIDE
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Clinical Studies
Right arrow Receptor pharmacology

Submitted on April 15, 2002
Revised on May 3, 2002

Effects of Doxazosin and Propranolol on A2A Adenosine Receptors in Essential Hypertension

Katia Varani; Roberto Manfredini; Valeria Iannotta; Cecilia Pancaldi; Elena Cattabriga; Canan Uluoglu; Pier Andrea Borea; and Francesco Portaluppi*

From the Pharmacology Unit (K.V., V.I., C.P., E.C., P.A.B.) and Hypertension Center (R.M., F.P.), Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, Italy; and Department of Pharmacology, Gazi University, Medical Faculty (C.U.), Ankara, Turkey.

* To whom correspondence should be addressed. E-mail: prf{at}unife.it.

Abstract—A2A adenosine receptors inhibit neutrophil adhesion and superoxide anion generation. The aim of the present study was to evaluate the effect of antihypertensive treatment with doxazosin or propranolol on the binding and functional parameters of A2A adenosine receptors of lymphocytes and neutrophils in essential hypertensive patients. Two groups of previously untreated, essential hypertensive patients were studied. The mean affinity (Kd) and density (Bmax) of adenosine receptors, by the A2A selective radioligand [3H]-ZM-241385 binding assays, and EC50, by cAMP assays, were obtained first on no medication and a second time after treatment for up to 13 weeks with doxazosin (13 patients) or propranolol (8 patients). A third group of 15 healthy normotensive volunteers matched by age, sex, and body mass index was used as a control. Binding and functional parameters of the A2A adenosine receptors were significantly higher in the 2 hypertensive groups than in controls (P always <0.0001), both in lymphocyte and neutrophil membranes. After treatment with propranolol, the binding parameters did not change significantly, whereas after treatment with doxazosin, Kd, Bmax, and EC50 values returned to control levels. In never-treated essential hypertensive patients, lower affinity, higher density, and impaired function of A2A adenosine receptors are present. The binding and functional parameters of A2A adenosine receptors appear to be normalized after treatment with doxazosin but not with propranolol.


Key words: adrenergic receptor blockers • antihypertensive agents • hypertension, essential • receptors, adenosine • assays




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
L. Carrega, E. Fenouillet, P. Giaime, A. Charavil, L. Mercier, V. Gerolami, J.-L. Berge-Lefranc, Y. Berland, J. Ruf, A. Saadjian, et al.
Influence of haemodialysis and left ventricular failure on peripheral A2A adenosine receptor expression
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 851 - 856.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Mukherjee, S. Baksi, R. A. Dart, S. Gollub, J. Lazar, C. Nair, D. Schroeder, and S. H. Woolf
{beta}-Blockers With Vasodilatory Actions
Chest, October 1, 2003; 124(4): 1621 - 1621.
[Full Text] [PDF]